Global and United States Prescription Digital Therapeutics (PDT) Market Report & Forecast 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Software
Publisher : MRA | Format : PDF
Global and United States Prescription Digital Therapeutics (PDT) Market Report & Forecast 2024-2034
Prescription digital therapeutics is a form of software-based therapeutics used to treat a wide range of illnesses. Technology and biology are combined to make prescription digital medications. These therapeutic tools were created using artificial intelligence, several algorithms, and virtual reality. Prescription PDTs, or digital therapeutics, are a brand-new medicinal category. PDTs act as direct treatments for critical disorders such as conventional biologics or medications.
Market Analysis and InsightsGlobal and United States Prescription Digital Therapeutics (PDT) Market
This report focuses on global and United States Prescription Digital Therapeutics (PDT) market, also covers the segmentation data of other regions in regional level and county level.
The global Prescription Digital Therapeutics (PDT) revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In United States the Prescription Digital Therapeutics (PDT) revenue is expected to grow from US$ million in 2023 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Prescription Digital Therapeutics (PDT) include Akili Interactive, Pear Therapeutics, Better Therapeutics, ResMed, Biofourmis, Novartis, Medtronic, Voluntis and Omada Health, etc. The global five biggest players hold a share of % in 2023.
Global Prescription Digital Therapeutics (PDT) Scope and Market Size
Prescription Digital Therapeutics (PDT) market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Prescription Digital Therapeutics (PDT) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the Prescription Digital Therapeutics (PDT) market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.
Akili Interactive
Pear Therapeutics
Better Therapeutics
ResMed
Biofourmis
Novartis
Medtronic
Voluntis
Omada Health
GAIA
Solera Network
BigHealth
Click Therapeutics
Happify
Limbix Health
Naturalcycles Nordic
NuvoAir
Sensyne Health
Xealth
Segment by Type
Medication Augmentation
Medication Replacement
Children
Adults
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter 1Introduces Prescription Digital Therapeutics (PDT) definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Prescription Digital Therapeutics (PDT) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Prescription Digital Therapeutics (PDT) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prescription Digital Therapeutics (PDT) revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
Market Analysis and InsightsGlobal and United States Prescription Digital Therapeutics (PDT) Market
This report focuses on global and United States Prescription Digital Therapeutics (PDT) market, also covers the segmentation data of other regions in regional level and county level.
The global Prescription Digital Therapeutics (PDT) revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In United States the Prescription Digital Therapeutics (PDT) revenue is expected to grow from US$ million in 2023 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Prescription Digital Therapeutics (PDT) include Akili Interactive, Pear Therapeutics, Better Therapeutics, ResMed, Biofourmis, Novartis, Medtronic, Voluntis and Omada Health, etc. The global five biggest players hold a share of % in 2023.
Global Prescription Digital Therapeutics (PDT) Scope and Market Size
Prescription Digital Therapeutics (PDT) market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Prescription Digital Therapeutics (PDT) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the Prescription Digital Therapeutics (PDT) market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.
By Company
Akili Interactive
Pear Therapeutics
Better Therapeutics
ResMed
Biofourmis
Novartis
Medtronic
Voluntis
Omada Health
GAIA
Solera Network
BigHealth
Click Therapeutics
Happify
Limbix Health
Naturalcycles Nordic
NuvoAir
Sensyne Health
Xealth
Segment by Type
Medication Augmentation
Medication Replacement
Segment by Application
Children
Adults
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1Introduces Prescription Digital Therapeutics (PDT) definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Prescription Digital Therapeutics (PDT) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Prescription Digital Therapeutics (PDT) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prescription Digital Therapeutics (PDT) revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices